A detailed history of American Portfolios Advisors transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, American Portfolios Advisors holds 6,100 shares of AVXL stock, worth $55,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,100
Holding current value
$55,693
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$8.9 - $12.86 $54,290 - $78,446
6,100 New
6,100 $63 Million
Q4 2021

Mar 21, 2023

SELL
$16.88 - $23.31 $10,128 - $13,986
-600 Reduced 9.84%
5,500 $95.4 Million
Q3 2021

Mar 22, 2023

SELL
$16.82 - $25.75 $10,092 - $15,450
-600 Reduced 9.84%
5,500 $98.7 Million
Q2 2021

Mar 22, 2023

SELL
$10.16 - $28.86 $6,096 - $17,316
-600 Reduced 9.84%
5,500 $126 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $712M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.